返回首页

对比阅读

对比阅读:AI Rejects, But Won't Explain Why — SHAP Matures Under Regulatory Pressure 与 AI 拒了客户却讲不出原因 — SHAP 这门技术正在被监管催熟

AEN
SHAPexplainabilityalgorithm regulation·

AI Rejects, But Won't Explain Why — SHAP Matures Under Regulatory Pressure

What this is

A technical post on Juejin recently caught our eye: the author pushed XGBoost to 0.93 accuracy on a breast cancer dataset, then spent most of the article on a more awkward fact — no matter how accurate the model, the first question from the business side is always "why was this case rejected?" The standard tool the post recommends is SHAP. It's not a new model — it's a mathematical method that decomposes a model's prediction into per-feature contributions, derived from the Shapley value in game theory, which answers the classic "how do you fairly divide a cake?" question. The core equation is simple: model output = baseline + each feature's contribution increment, and each increment can be attributed by name — "this feature pushed the score up by 0.32."

Industry view

We see two camps pulling in opposite directions. The pro side: explainability is already a compliance necessity. The EU AI Act took effect in 2024, and China's Interim Measures for the Management of Generative AI Services also requires algorithmic traceability; any bank, insurer, or hospital using AI for loan rejections, claim denials, or assisted diagnosis must explain "why" to regulators and to customers. The con side is equally sharp: many companies think installing SHAP is enough, but four common misreadings are creating new compliance risks — treating SHAP as causation (it's actually correlation), reading SHAP values without a baseline (increments without a baseline are nonsense), having correlated features dilute each other's contribution (two highly correlated features split the credit), and assuming TreeExplainer is exact for all models (it's only exact for tree models; everything else is an approximation). Tool bought, problem unsolved.

Impact on regular people

  • Enterprise IT: explainability platform procurement budgets will rise this year. Risk control, lending, healthcare, and HR are the hardest hit.
  • Individual careers: non-technical managers also need to get this. Stop chasing accuracy — start asking "why." This is the new baseline for working with AI.
  • Consumer market: when AI rejects your loan, claim, or job offer, you'll increasingly have the right to demand a plain-language explanation.
来源: juejin.cn
BZH
SHAP可解释性算法监管·

AI 拒了客户却讲不出原因 — SHAP 这门技术正在被监管催熟

这是什么

掘金上一篇技术文章最近进入我们视野:作者把 XGBoost 在乳腺癌数据集上做到 0.93 准确率,然后花大篇幅讲了一个更尴尬的事 — 模型再准,业务方第一反应永远是问"这一单为什么被拒"。文章给出的标准答案工具叫 SHAP,它不是新模型,而是一套把模型预测值拆给每个特征的数学方法,源自博弈论里"蛋糕怎么分才公平"的 Shapley 值。核心等式很简单:模型输出 = 基线 + 每个特征的贡献增量,每一份都能指名道姓说"是这个特征,推高了 0.32"。

行业怎么看

我们看到两类声音在拉锯。正方说:可解释性已经是合规刚需,欧盟 AI 法案 2024 年生效,中国《生成式 AI 服务管理暂行办法》也要求算法可追溯;银行、保险、医院但凡用模型做拒贷、拒赔、辅助诊断,都得能跟监管、跟客户讲清楚"为什么"。反方意见同样尖锐:很多企业以为装上 SHAP 就万事大吉,四个误读正在制造新的合规风险 — 把 SHAP 当因果(其实只是相关性)、脱离基线看 SHAP 值(没有基准的增量是废话)、相关特征贡献被摊薄(两个高度相关的特征会分掉功劳)、TreeExplainer 只对树模型精确(其他模型给的是近似)。工具买了,问题没解决。

对普通人的影响

  • 企业 IT:今年可解释性平台的采购预算会涨,风控、信贷、医疗、HR 是重灾区。
  • 个人职场:非技术管理者也得懂,不追准确率,要追问"为什么" — 这是和 AI 协作的新基本功。
  • 消费市场:以后被 AI 拒贷、拒赔、拒 offer,你越来越有权利要求对方给一个白话版理由。
来源: juejin.cn